{"filing":{"accession_number":"0001193125-26-387960","cik":"0001756262","ticker":"TMDX","company_name":"TransMedics Group, Inc.","form":"8-K","filing_date":"2026-09-10","report_date":"2026-09-10","primary_document":"d116447d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1756262/000119312526387960/d116447d8k.htm"},"events":[{"id":32715,"run_id":30077,"accession_number":"0001193125-26-387960","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.94,"summary":"TransMedics appointed Fernando Araujo as Chief Financial Officer and Treasurer, effective September 21, 2026, succeeding Gerardo Hernandez. Araujo brings over 20 years of public-company finance leadership from GE HealthCare, 3M, and GE, with a compensation package including $590,000 base salary, $200,000 sign-on bonus, and approximately $3.5 million in equity awards.","company_name":"TransMedics Group, Inc.","ticker":"TMDX","filing_date":"2026-09-10","form":"8-K","submitted_at":null,"items":[{"id":35959,"accession_number":"0001193125-26-387960","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the appointment of Fernando Araujo as Chief Financial Officer and Treasurer, effective September 21, 2026, succeeding Gerardo Hernandez. While the section also describes Hernandez's transition to a non-executive role and then advisory position (a departure component), the principal disclosed action centers on Araujo's appointment to the CFO role. The detailed compensation arrangements ($590,000 base salary, $200,000 sign-on bonus, ~$3.5M in equity awards) and his extensive background at GE HealthCare, 3M, and GE underscore the materiality of this executive appointment to investors assessing leadership continuity and financial stewardship.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-10T20:41:43.878792+00:00","company_name":"","ticker":null,"filing_date":""},{"id":35960,"accession_number":"0001193125-26-387960","item_number":"7.01","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing announces the appointment of Fernando Araujo as Chief Financial Officer effective September 21, 2026, replacing Gerardo Hernandez who transitions to a different role. While the press release also mentions Hernandez's transition to Commercial Strategic Advisor for LATAM expansion, the principal disclosed action centers on the CFO appointment of a new executive with 20+ years of public-company finance leadership at major healthcare and industrial companies. This is a material executive appointment affecting the registrant's financial leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-10T20:41:43.878792+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":35959,"accession_number":"0001193125-26-387960","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the appointment of Fernando Araujo as Chief Financial Officer and Treasurer, effective September 21, 2026, succeeding Gerardo Hernandez. While the section also describes Hernandez's transition to a non-executive role and then advisory position (a departure component), the principal disclosed action centers on Araujo's appointment to the CFO role. The detailed compensation arrangements ($590,000 base salary, $200,000 sign-on bonus, ~$3.5M in equity awards) and his extensive background at GE HealthCare, 3M, and GE underscore the materiality of this executive appointment to investors assessing leadership continuity and financial stewardship.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-10T20:41:43.878792+00:00","company_name":"TransMedics Group, Inc.","ticker":"TMDX","filing_date":"2026-09-10"},{"id":35960,"accession_number":"0001193125-26-387960","item_number":"7.01","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing announces the appointment of Fernando Araujo as Chief Financial Officer effective September 21, 2026, replacing Gerardo Hernandez who transitions to a different role. While the press release also mentions Hernandez's transition to Commercial Strategic Advisor for LATAM expansion, the principal disclosed action centers on the CFO appointment of a new executive with 20+ years of public-company finance leadership at major healthcare and industrial companies. This is a material executive appointment affecting the registrant's financial leadership.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-10T20:41:43.878792+00:00","company_name":"TransMedics Group, Inc.","ticker":"TMDX","filing_date":"2026-09-10"}]}